Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib.
Youngeun LeeEun Ju ChoSu Jong YuYoon Jun KimJung-Hwan YoonTae-Yong KimSae-Won HanDo-Youn OhSeock-Ah ImTae-You KimHaeryoung KimKyung-Hun LeePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Avelumab showed moderate efficacy and was well tolerated in advanced hepatocellular carcinoma previously treated with sorafenib.